CanSino Biologics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003F01
HKD
37.92
0.2 (0.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
894.36
381.43
1,198.98
5,182.05
20.84
0.00
1.34
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
894.36
381.43
1,198.98
5,182.05
20.84
0.00
1.34
Raw Material Cost
389.75
1,472.77
1,511.89
1,611.23
41.79
25.48
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
492.95
782.10
776.12
652.37
231.33
132.31
90.53
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
65.23
71.10
48.64
24.94
30.90
0.11
0.00
Selling and Distribution Expenses
590.02
686.06
602.28
394.02
105.32
55.41
51.10
Other Expenses
-19.45
-22.51
2.57
34.81
19.72
1.91
3.14
Total Expenditure (Excl Depreciation)
1,343.48
2,786.89
2,964.60
3,030.69
606.55
232.38
173.05
Operating Profit (PBDIT) excl Other Income
-449.09999999999997
-2405.5
-1765.6
2151.3999999999996
-585.7
-232.39999999999998
-171.70000000000002
Other Income
125.88
304.92
439.39
123.69
166.08
71.28
24.24
Operating Profit (PBDIT)
-91.58
-1,800.85
-1,056.06
2,380.21
-384.32
-135.89
-150.04
Interest
65.23
71.10
48.64
24.94
30.90
0.11
0.00
Exceptional Items
-6.66
-16.08
-4.72
85.68
5.28
-16.28
0.00
Gross Profit (PBDT)
504.60
-1,091.34
-312.92
3,570.82
-20.95
-25.48
0.00
Depreciation
231.66
299.98
267.42
106.71
35.75
25.48
13.75
Profit Before Tax
-395.13
-2,188.01
-1,376.85
2,334.24
-445.70
-177.76
-163.79
Tax
2.67
-12.65
-254.95
35.80
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-410.80
-1,638.42
-1,057.56
2,307.24
-445.70
-177.76
-163.79
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-410.80
-1,638.42
-1,057.56
2,307.24
-445.70
-177.76
-163.79
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-5.19
-535.59
-64.34
-8.80
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-415.99
-2,174.01
-1,121.89
2,298.44
-445.70
-177.76
-163.79
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.06
1.1
1.12
1.22
1.19
0.0
0.0
Reserves
5,225.15
5,807.37
7,576.35
9,780.06
7,197.85
1,644.91
572.82
Earnings per share (EPS)
-1.66
-6.64
-4.28
9.32
-1.93
-0.87
-0.74
Diluted Earnings per share
-1.66
-6.64
-4.28
9.32
-1.93
-0.87
-0.74
Operating Profit Margin (Excl OI)
-50.22%
-630.72%
-147.03%
41.49%
-2812.93%
0.0%
-14023.41%
Gross Profit Margin
-18.28%
-494.99%
-92.53%
47.1%
-1967.33%
0.0%
-11190.11%
PAT Margin
-45.93%
-429.55%
-88.21%
44.52%
-2138.9%
0.0%
-12215.64%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 134.50% vs -68.19% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 80.86% vs -93.78% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 89.67% vs -40.81% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -8.30% vs 46.30% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of CanSino Biologics, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
894.36
2,034.39
-1,140.03
-56.04%
Other Operating Income
0.00
0.00
0.00
Total Operating income
894.36
2,034.39
-1,140.03
-56.04%
Raw Material Cost
389.75
1,420.65
-1,030.90
-72.57%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
492.95
878.24
-385.29
-43.87%
Power Cost
0
0
0.00
Manufacturing Expenses
65.23
55.37
9.86
17.81%
Selling and Distribution Expenses
590.02
412.58
177.44
43.01%
Other Expenses
-19.45
-88.63
69.18
78.05%
Total Expenditure (Excl Depreciation)
1,343.48
1,880.50
-537.02
-28.56%
Operating Profit (PBDIT) excl Other Income
-449.12
153.89
-603.01
-391.84%
Other Income
125.88
33.15
92.73
279.73%
Operating Profit (PBDIT)
-91.58
465.55
-557.13
-119.67%
Interest
65.23
55.37
9.86
17.81%
Exceptional Items
-6.66
-18.82
12.16
64.61%
Gross Profit (PBDT)
504.60
613.74
-109.14
-17.78%
Depreciation
231.66
278.51
-46.85
-16.82%
Profit Before Tax
-395.13
112.85
-507.98
-450.14%
Tax
2.67
30.13
-27.46
-91.14%
Provisions and contingencies
0
0
0.00
Profit After Tax
-410.80
84.62
-495.42
-585.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-410.80
84.62
-495.42
-585.46%
Share in Profit of Associates
0
0
0.00
Minority Interest
-5.19
-0.63
-4.56
-723.81%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-415.99
83.99
-499.98
-595.29%
Equity Capital
0
0
0.00
Face Value
1.06
0.00
0.00
Reserves
5,225.15
2,674.45
2,550.70
95.37%
Earnings per share (EPS)
-1.66
0.04
-1.70
-4,250.00%
Diluted Earnings per share
-1.66
0.04
-1.70
-4,250.00%
Operating Profit Margin (Excl OI)
-50.22%
7.56%
0.00
-57.78%
Gross Profit Margin
-18.28%
19.24%
0.00
-37.52%
PAT Margin
-45.93%
4.16%
0.00
-50.09%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 89.44 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 134.50% vs -68.19% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit -41.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 80.86% vs -93.78% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -21.75 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 89.67% vs -40.81% in Dec 2023

Annual - Interest
Interest 6.52 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -8.30% vs 46.30% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -50.22%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023